Data from a metoclopramide (MCP)-induced hyperprolactinemia mouse model showed that oral administration of HY7801 reduced serum levels of prolactin and pro-inflammatory cytokines significantly, while restoring hormone imbalances caused by MCP. This evidence concerns the gene PRL and hyperprolactinemia.